TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.

This is being partially offset by growth in strategic partnerships ... ICLR was down by 9.12 percent at $198.10 in the pre-market trade on the Nasdaq. Icon PLCShs NewsMORE Related Stocks Indices ...